4.5 Editorial Material

Jasper's Basic Mechanisms of the Epilepsies Workshop

Journal

EPILEPSIA
Volume 51, Issue -, Pages 1-5

Publisher

WILEY
DOI: 10.1111/j.1528-1167.2010.02792.x

Keywords

Antiepileptic therapies; Brain development; Classification; Epileptogenesis; Genetics; Epilepsy; Neuronal excitability; Seizures

Funding

  1. NINDS NIH HHS [R01 NS029709-19S1, R01 NS029709, R13 NS063608] Funding Source: Medline

Ask authors/readers for more resources

P>In 1969, H.H. Jasper, A.A. Ward, and A. Pope and the Public Health Service Advisory Committee on the Epilepsies of the National Institutes of Health (NIH) published the first edition on Basic Mechanisms of the Epilepsies (BME). Since then, basic and clinical researchers in epilepsy have gathered together each decade to assess where epilepsy research has been, what it has accomplished, and where it should go. In 1999, the third edition of BME was named in honor of H.H. Jasper. Projected for publication in 2011, the fourth edition of Jasper's BME will (1) synthesize the role of interactions between neurons, synapses, and glia in the initiation, spread, and arrest of seizures; (2) examine the molecular, cellular, and network plasticity mechanisms that subserve excitability, seizure susceptibility, and ultimately epileptogenesis; (3) provide a framework for expanding the genome of rare mendelian epilepsies and understanding the complex heredity responsible for common epilepsies; (4) explore cellular mechanisms of the two main groups of presently known Mendelian epilepsy genes, namely ion channelopathies and developmental epilepsy genes; and (5) for the first time, describe the current efforts to translate the discoveries in epilepsy disease mechanisms into molecular and cellular therapeutic strategies in order to repair and cure the epilepsies. For an expanded treatment of this topic see Jasper's Basic Mechanisms of the Epilepsies, Fourth Edition (Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds) published by Oxford University Press (available on the National Library of Medicine Bookshelf [NCBI] at http://www.ncbi.nlm.nih.gov/books).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Toxicology

The chemical convulsant diisopropylfluorophosphate (DFP) causes persistent neuropathology in adult male rats independent of seizure activity

Eduardo A. Gonzalez, Alexa C. Rindy, Michelle A. Guignet, Jonas J. Calsbeek, Donald A. Bruun, Ashish Dhir, Peter Andrew, Naomi Saito, Douglas J. Rowland, Danielle J. Harvey, Michael A. Rogawski, Pamela J. Lein

ARCHIVES OF TOXICOLOGY (2020)

Review Neurosciences

Mechanisms of action of currently used antiseizure drugs

Graeme J. Sills, Michael A. Rogawski

NEUROPHARMACOLOGY (2020)

Article Clinical Neurology

Night Watch on the Titanic: Detecting Early Signs of Epileptogenesis in Alzheimer Disease

Alice D. Lam, Jeffrey Noebels

EPILEPSY CURRENTS (2020)

Article Clinical Neurology

Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery

Dorota Zolkowska, Chun-Yi Wu, Michael A. Rogawski

Summary: Allopregnanolone administered intranasally rapidly elevates seizure threshold with minimal adverse effects, showing direct nose-to-brain delivery and preferential distribution in brain regions relevant to seizures compared to benzodiazepines. Intranasal delivery of allopregnanolone provides a rapid and effective treatment option for seizures, overcoming potential refractoriness to benzodiazepines.

NEUROTHERAPEUTICS (2021)

Article Toxicology

Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam

Dorota Zolkowska, Ashish Dhir, Michael A. Rogawski

Summary: The study found that perampanel and diazepam can effectively protect against TETS-induced tonic seizures and lethality, but have less impact on clonic seizures.

ARCHIVES OF TOXICOLOGY (2021)

Article Clinical Neurology

Cortical excitability threshold can be increased by the AMPA blocker Perampanel in amyotrophic lateral sclerosis

Bjorn Oskarsson, Elizabeth A. Mauricio, Jaimin S. Shah, Zhuo Li, Michael A. Rogawski

Summary: This study aimed to evaluate transcranial magnetic stimulation (TMS) as a functional assessment tool for studying the effects of perampanel in ALS patients. Results demonstrated that perampanel affects the physiology of upper motor neurons, and motor threshold may serve as a marker of biological target engagement.

MUSCLE & NERVE (2021)

Article Clinical Neurology

Proceedings of the Sleep and Epilepsy Workshop: Section 3 Mortality: Sleep, Night, and SUDEP

Gordon F. Buchanan, Bruce J. Gluckman, Franck K. Kalume, Samden Lhatoo, Rama K. Maganti, Jeffrey L. Noebels, Kristina A. Simeone, Mark S. Quigg, Milena K. Pavlova

Summary: SUDEP is the leading cause of death in patients with refractory epilepsy, with likely pathophysiological mechanisms including cardiac and respiratory dysregulation. SUDEP cases frequently occur at night, raising the question of a role for sleep in its regulation. Studies have identified an association with sleep in SUDEP and animal models, emphasizing the importance of understanding the role of sleep and time of day in its pathophysiology.

EPILEPSY CURRENTS (2021)

Article Pharmacology & Pharmacy

Intravenous and Intramuscular Allopregnanolone for Early Treatment of Status Epilepticus: Pharmacokinetics, Pharmacodynamics, and Safety in Dogs

Irene Vuu, Edward E. Patterson, Chun-Yi Wu, Dorota Zolkowska, Ilo E. Leppik, Michael A. Rogawski, Gregory A. Worrell, Vaclav Kremen, James C. Cloyd, Lisa D. Coles

Summary: This study characterizes the pharmacokinetics and pharmacodynamics of allopregnanolone, providing a basis for designing clinical studies evaluating its effectiveness as an early treatment for status epilepticus in dogs and people.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)

Article Neurosciences

Strain differences in the extent of brain injury in mice after tetramethylenedisulfotetramine-induced status epilepticus

Jonas J. Calsbeek, Eduardo A. Gonzalez, Casey A. Boosalis, Dorota Zolkowska, Donald A. Bruun, Douglas J. Rowland, Naomi H. Saito, Danielle J. Harvey, Abhijit J. Chaudhari, Michael A. Rogawski, Joel R. Garbow, Pamela J. Lein

Summary: Acute intoxication with tetramethylenedisulfotetramine (TETS) can trigger status epilepticus (SE) in humans. Survivors often exhibit long-term neurological effects, but the pathogenic mechanisms are not known. In this study, advanced in vivo imaging techniques were used to monitor the neuropathological consequences of TETS-induced SE in different mouse strains, revealing strain-specific differences in brain injury and neuroinflammation.

NEUROTOXICOLOGY (2021)

Article Cell Biology

Kctd7 deficiency induces myoclonic seizures associated with Purkinje cell death and microvascular defects

Justine H. Liang, Jonathan Alevy, Viktor Akhanov, Ryan Seo, Cory A. Massey, Danye Jiang, Joy Zhou, Roy V. Sillitoe, Jeffrey L. Noebels, Melanie A. Samuel

Summary: Mutations in the KCTD7 gene are associated with a severe neurodegenerative phenotype characterized by childhood onset of progressive and intractable myoclonic seizures accompanied by developmental regression. Kctd7-deficient mice develop similar symptoms, indicating that Kctd7 is involved in the pathogenesis of KCTD7-related diseases. Furthermore, Kctd7 is required for Purkinje cell survival in the cerebellum and is linked to microvascular alterations in vulnerable regions.

DISEASE MODELS & MECHANISMS (2022)

Article Clinical Neurology

A randomized, open-label, two-treatment crossover study to evaluate the effect of food on the pharmacokinetics of diazepam nasal spray in healthy adults

Michael A. A. Rogawski, Gary Slatko

Summary: The pharmacokinetics of diazepam nasal spray can be affected by food, resulting in decreased and delayed absorption compared to fasting conditions. This study found that under fed conditions, the maximum plasma diazepam concentration and overall exposure were significantly reduced compared to fasted conditions. The time to reach maximum plasma concentration was also longer in the fed state. This has important implications for patients using diazepam nasal spray, as they may not achieve therapeutic concentrations if used after eating.

EPILEPSIA (2023)

Article Clinical Neurology

Tolerability and pharmacokinetics of intravenous allopregnanolone with and without midazolam pretreatment in two healthy dogs

Donald A. Bruun, Betty Ma, Yi-Je Chen, Chun-Yi Wu, Monica Aleman, Dorota Zolkowska, Suzette M. Smiley-Jewell, Michael A. Rogawski, Pamela J. Lein

Summary: The study assessed the cardiopulmonary safety of intravenous ALLO for treating benzodiazepine-refractory SE. The results showed that intravenous ALLO can be used safely to treat benzodiazepine-refractory SE, even when administered shortly after a benzodiazepine.

EPILEPSIA OPEN (2023)

Meeting Abstract Clinical Neurology

The Impact of Disease Severity on Efficacy from a Phase 2b Study of XEN1101, A Novel Potassium Channel Opener, in Adults With Focal Epilepsy (X-TOLE)

Christopher Kenney, Jacqueline French, Roger Porter, Emilio Perucca, Martin Brodie, Michael A. Rogawski, Cynthia Harden, Jenny Qian, Greg Beatch

NEUROTHERAPEUTICS (2022)

Meeting Abstract Clinical Neurology

Phase 2B Efficacy and Safety of XEN1101, a Novel Potassium Channel Modulator, In Adults with Focal Epilepsy (X-TOLE)

Jacqueline French, Roger Porter, Emilio Perucca, Martin Brodie, Michael A. Rogawski, Simon Pimstone, Ernesto Aycardi, Cynthia Harden, Yi Xu, Constanza Luzon Rosenblut, Christopher Kenney, Greg Beatch

NEUROTHERAPEUTICS (2022)

No Data Available